Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Systemic Sclerosis & Related Disorders – Clinical Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0671: The Gut-Heart Axis in Systemic Sclerosis: Evidence from the GENISOS cohort
    Location: Hall F1
    Abstract Poster Presenter: Ali Ayla, MD – UPMC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0672: Determinants of Progressive Microstomia in Systemic Sclerosis: Insights from the GENISOS Cohort with a Focus on GI Involvement
    Location: Hall F1
    Abstract Poster Presenter: Ashish Balar, MBBS, MPH – The University of Texas Health Science Center Houston
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0673: Association Between Vasoactive-vasodilating Therapy and Reduced Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: Evidence from a EUSTAR Study
    Location: Hall F1
    Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0674: Quantitative Imaging in Systemic Sclerosis Patients Receiving Sodium Thiosulfate for Calcinosis Cutis
    Location: Hall F1
    Abstract Poster Presenter: Crystal Cheung, MS – Yale University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0675: Neutrophil-to-Lymphocyte Ratio as a biomarker for disease onset and a predictor for mortality in Systemic Sclerosis – real-world data from a large healthcare provider in Israel.
    Location: Hall F1
    Abstract Poster Presenter: Doron Rimar, MD (he/him/his) – Bnai Zion medical center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0676: Engineered glove for the objective assessment of hand dexterity in patients with systemic sclerosis: correlations with clinical features, nailfold videocapillaroscopy, and high frequency skin ultrasonography
    Location: Hall F1
    Abstract Poster Presenter: Elvis Hysa, MD – University of Genova
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0677: Increased incidence of sudden cardiac death in systemic sclerosis: estimate & correlates.
    Location: Hall F1
    Abstract Poster Presenter: Laura Ross, MBBS PhD FRACP – The University of Melbourne
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0678: Targeting the plasma cell niche in systemic sclerosis: A case series about the bispecific anti-BCMAxCD3 antibody teclistamab in severe, treatment-refractory patients
    Location: Hall F1
    Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0679: Inhibition of TGFb3 in Systemic Sclerosis Patients Does Not Result in TGFb Pathway Modulation in Skin Biopsies or Circulation
    Location: Hall F1
    Abstract Poster Presenter: Xuting (Rebecca) Sheng, PhD – Genentech
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0680: Altered Mirna Patterns of Peripheral Blood Mononuclear Cells Show Correlations with Pulmonary Manifestations of Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Zoltan Szekanecz, MD, PhD – University of Debrecen
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0681: Evaluation of Serial Cardiovascular Magnetic Resonance Monitoring and Immunosuppressive Therapy in Predicting Long-Term Outcomes in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Aïcha Kante, MD, MSc – Université Paris Cité
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0682: Predictors of Severe Outcomes in Scleroderma Renal Crisis: Updated Results from a Single Center Study
    Location: Hall F1
    Abstract Poster Presenter: Alex Luta, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0683: Symptom-Based Clustering of Gastrointestinal Involvement in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Ali Ayla, MD – UPMC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0684: Translation to Spanish and Linguistic Validation of the Assessment of Systemic Sclerosis-associated Raynaud's Phenomenon (ASRAP)
    Location: Hall F1
    Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0685: Targeting Refractory Reflux in Systemic Sclerosis: Early Outcomes following a Novel Intervention
    Location: Hall F1
    Abstract Poster Presenter: Areeka Memon, DO, MPH – Yale New Haven Health
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0686: Use of a Smartphone App which Incorporates Feedback to Patients to Monitor Systemic Sclerosis-related Digital Ulcers – a Potential New Tool for Remote Clinical Monitoring
    Location: Hall F1
    Abstract Poster Presenter: Ariane Herrick, MD – The University of Manchester, UK
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0687: Distinct Cancer Risk Profiles in Patients with Systemic Sclerosis with Autoantibody Stratification
    Location: Hall F1
    Abstract Poster Presenter: Arjun Mahajan, MS – Harvard Medical School
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0688: Total lung capacity is predictive of disease severity and survival in systemic sclerosis: a longitudinal analysis in 2347 patients from the French National Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Benjamin Chaigne, MD, PhD – Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0689: Development of an Articular Activity Score in Systemic Sclerosis (ASSESS): Identifying Core Instruments for Disease Activity Assessment
    Location: Hall F1
    Abstract Poster Presenter: Blaz Burja, MD – Zurich, Switzerland
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0690: Quantitative 18F-FDG PET-CT of the lungs detects treatment induced changes in patients with early severe diffuse cutaneous systemic sclerosis and interstitial lung disease
    Location: Hall F1
    Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0691: Association of Elevated Platelets and CRP with Severe Disease and Poor Survival in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Brian Lee, MD, MS, FACP – Stanford University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0692: A Randomised Open Label Pilot Trial Comparing Mycophenolate Mofetil with No Immunosuppression in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
    Location: Hall F1
    Abstract Poster Presenter: Christopher Denton, MD, PhD (he/him/his) – University College London
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0693: Impact of X Chromosome Dosage on the Development of Diffuse and Limited Systemic Sclerosis in Klinefelter, Triple X, and Turner Syndromes: A Multicenter Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Hanieh Akbari, MD – Jefferson Einstein Montgomery Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0694: Treatment of Sjögren’s disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod
    Location: Hall F1
    Abstract Poster Presenter: isabelle peene, MD,PhD – University Hospital Ghent
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0695: Global Longitudinal, Circumferential, and Radial Strain in Systemic Sclerosis Patients with Left Ventricular Dysfunction
    Location: Hall F1
    Abstract Poster Presenter: Jennifer Abdalla, MD, MS – LSU Health Sciences Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0696: WITHDRAWN
    Location: Hall F1
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0698: A Retrospective Comparison of Transplant Outcomes with Different Induction Methods and Maintenance Prednisone in Systemic Sclerosis Patients
    Location: Hall F1
    Abstract Poster Presenter: Lilit Grigoryan, DO – Albany Medical College
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0699: A Retrospective Comparison of Transplant Outcomes in Patients with and Without Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Lilit Grigoryan, DO – Albany Medical College
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0700: Distinct Breath Metabolomic Signature in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension
    Location: Hall F1
    Abstract Poster Presenter: Lorenzo Beretta, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0701: Exploring Calcinosis On Hand X-Rays In Systemic Sclerosis: a Mayo Clinic Cohort
    Location: Hall F1
    Abstract Poster Presenter: Maximiliano Diaz Menindez, MD (he/him/his) – Mayo Clinic School of Graduate Medical Education
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0702: Effectiveness of Oral Anticoagulants in Precapillary Pulmonary Hypertension Associated with Systemic Sclerosis: a EUSTAR Cohort Study.
    Location: Hall F1
    Abstract Poster Presenter: Nicola Farina, MD – IRCCS San Raffaele Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0703: Trends and Disparities in Systemic Sclerosis-related Mortality Rates in the United States from 1999 to 2023
    Location: Hall F1
    Abstract Poster Presenter: Nicolas Barnechea Alvarado, MD (he/him/his) – Kirk Kerkorian School of Medicine at UNLV
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0704: Human Pharmacokinetics of Inhaled Liposomal Iloprost Support a Dosing Regimen for Treating Systemic Sclerosis- Related Digital Ulcer
    Location: Hall F1
    Abstract Poster Presenter: Pei Kan, n/a (he/him/his) – Pharmosa Biopharm Inc
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0705: Multimodal Imaging Evaluation of Patients with Raynaud's Phenomenon meeting the Criteria for "Early" Systemic Sclerosis according to LeRoy versus Healthy Controls: a Prospective Cross-sectional study
    Location: Hall F1
    Abstract Poster Presenter: RAMONA GOVENDER, MBChB, MMed – University of Ghent
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0706: Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study
    Location: Hall F1
    Abstract Poster Presenter: Roberto D'Alessandro, MS – APHP
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0706: Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study
    Location: Hall F1
    Abstract Poster Presenter: Roberto D'Alessandro, MS – APHP
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0707: When Can Support Lead to Missed Clinic Appointments in Patients with Systemic Lupus Erythematosus?
    Location: Hall F1
    Abstract Poster Presenter: Samiha Karim, MD – Emory University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0708: Association of Choroidal Sub-foveal Thickness with Skin Manifestations and Serum Monocyte HDL Ratio in Patients with Systemic Sclerosis-a Case Control Study
    Location: Hall F1
    Abstract Poster Presenter: Tejaswini Ramineni, n/a (she/her/hers) – Esic Medical College And Hospital, Sanathnagar
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0709: Systemic Sclerosis Inducible Pluripotential Stem Cells Reprogrammed into Endothelial Cells Identify Vascular Permeability May Not Be Cytokine Driven
    Location: Hall F1
    Abstract Poster Presenter: Tracy Frech, MD, MS – Vanderbilt University Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0710: Vascular Events in Systemic Sclerosis Patients with Anti-Phospholipid Antibodies
    Location: Hall F1
    Abstract Poster Presenter: Vivian Shing, BS – Mayo Clinic Alix School of Medicine
  • Sunday, Oct 26th
    1:00 PM - 2:30 PM Central Time
    26S29: Abstracts: Systemic Sclerosis & Related Disorders – Basic Science
    Location: S105
    Abstract Moderator: Benjamin Korman, MD – University of Rochester
    Abstract Moderator: Maria Teves, DrPH – Virginia Commonwealth University
     CE: 0.00
  • Sunday, Oct 26th
    1:00 PM - 1:15 PM Central Time
    0807: Deciphering Synovitis in Systemic Sclerosis
    Location: S105
    Presenting Author: Celina Geiss, BSc, MSc (she/her/hers) – University of Zurich & University Hospital Zurich
  • Sunday, Oct 26th
    1:15 PM - 1:30 PM Central Time
    0808: Spatial Transcriptomics Show Fibroblast LIF Receptor Drives Fibrosis in Systemic Sclerosis
    Location: S105
    Presenting Author: Mari Kamiya, MD, PhD – Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
  • Sunday, Oct 26th
    1:30 PM - 1:45 PM Central Time
    0809: Human blood vessel organoids as a model of vasculopathy in systemic sclerosis
    Location: S105
    Presenting Author: Alexandru-Emil Matei, -None- – University Hospital Düsseldorf
  • Sunday, Oct 26th
    1:45 PM - 2:00 PM Central Time
    0810: Spatial Transcriptomic-based Phenotyping of the Fibroblast Niches in Systemic Sclerosis-associated Primary Heart Involvement
    Location: S105
    Presenting Author: Alexandru Micu, MD – Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University.
  • Sunday, Oct 26th
    2:00 PM - 2:15 PM Central Time
    0811: SSc Skin Cell Atlas: a Scalable Web Portal for scRNA-Seq Analysis
    Location: S105
    Presenting Author: Helen Jarnagin, BA – Dartmouth College
  • Sunday, Oct 26th
    2:15 PM - 2:30 PM Central Time
    0812: anti-cd206 CAR T Cell Immunotherapy Mitigates Dermal Pathology in Systemic Sclerosis
    Location: S105
    Presenting Author: Chanhyuk Park, BA – Geisel School of Medicine at Dartmouth
  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S69: Abstracts: Systemic Sclerosis & Related Disorders – Clinical I
    Location: W192A-C
    Abstract Moderator: Robyn Domsic, MD, MPH – University of Pittsburgh
    Abstract Moderator: Lauren Smith, MD – Medstar Georgetown University Hospital
     CE: 0.00
  • Sunday, Oct 26th
    3:00 PM - 3:15 PM Central Time
    0843: Efficacy and Safety of BMS-986353, a CD19-Directed Chimeric Antigen Receptor T Cell Therapy Manufactured Using a Next-Generation Process: Updated Data From a Phase 1 Trial in Patients With Systemic Sclerosis
    Location: W192A-C
    Presenting Author: Dinesh Khanna, MD, MSc – University of Michigan
  • Sunday, Oct 26th
    3:15 PM - 3:30 PM Central Time
    0844: Machine Learning Model Incorporating Baseline and Early Follow-up Clinical Data Predicts 52-Week Cutaneous Outcomes in Systemic Sclerosis
    Location: W192A-C
    Presenting Author: Kimberly Lakin, MD, MS – Hospital for Special Surgery
  • Sunday, Oct 26th
    3:30 PM - 3:45 PM Central Time
    0845: Machine Learning–Based Skin Transcriptome Classifier (v2.0) Links SSc Molecular Subtypes to Disease Severity and Progression
    Location: W192A-C
    Presenting Author: Zhiyun Gong, MS, BSc – Dartmouth College
  • Sunday, Oct 26th
    3:45 PM - 4:00 PM Central Time
    0846: A Longitudinal Transcriptomic Study of Mycophenolate Mofetil in Systemic Sclerosis Skin with Clinical and Molecular Stratification
    Location: W192A-C
    Presenting Author: Rezvan Parvizi, PharmD;MSc – Dartmouth College
  • Sunday, Oct 26th
    4:00 PM - 4:15 PM Central Time
    0847: Interferon Score Effectively Stratifies for Time to Clinically Significant Event Accrual in Systemic Sclerosis Independently of Cutaneous Subset
    Location: W192A-C
    Presenting Author: Francesco Del Galdo, MD,PhD – University of Leeds
  • Sunday, Oct 26th
    4:15 PM - 4:30 PM Central Time
    0848: Spatial Frequency Domain Imaging (SFDI) for Skin Assessment in Systemic Sclerosis: Insights from Histology and Clinical Correlates
    Location: W192A-C
    Presenting Author: Hung Vo, MD;RhMSUS (he/him/his) – Boston Medical Center
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M17: Abstracts: Systemic Sclerosis & Related Disorders – Clinical II
    Location: S102
    Abstract Moderator: Tatiana Rodríguez Reyna, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
    Abstract Moderator: Andrew Gross, MD – UCSF
     CE: 0.00
  • Monday, Oct 27th
    10:00 AM - 10:15 AM Central Time
    0879: Trajectories and risk factors of interstitial lung disease in limited cutaneous systemic sclerosis from the EUSTAR cohort
    Location: S102
    Presenting Author: Antonio Tonutti, MD – Humanitas University
  • Monday, Oct 27th
    10:15 AM - 10:30 AM Central Time
    0880: Detecting Interstitial Lung Disease and Identifying Extensive Disease on Chest Computed Tomography in Patients with Systemic Sclerosis: Cut-Offs for Lung Texture Analysis and its Prognostic Implications
    Location: S102
    Presenting Author: Cosimo Bruni, MD, PhD – University of Zurich
  • Monday, Oct 27th
    10:30 AM - 10:45 AM Central Time
    0881: Circulating Monocytes with High Interferon Signature as Precursors to Osteopontin Expressing Lung Macrophages in Patients with Systemic Sclerosis and Progressive Interstitial Lung Disease
    Location: S102
    Presenting Author: Richard Ainsworth, PhD – Cedars Sinai Medical Center
  • Monday, Oct 27th
    10:45 AM - 11:00 AM Central Time
    0882: Serum KL-6 as a Predictive Biomarker for Interstitial Lung Disease Progression and Mortality in Systemic Sclerosis: A Prospective Cohort Study
    Location: S102
    Presenting Author: Cristiana Sieiro Santos, MD – Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
  • Monday, Oct 27th
    11:00 AM - 11:15 AM Central Time
    0883: Predictive Significance of Serum Proteins for the Course of Systemic Sclerosis-Related Interstitial Lung Disease in the Multicenter CONQUER Cohort
    Location: S102
    Presenting Author: Ali Ayla, MD – UPMC
  • Monday, Oct 27th
    11:15 AM - 11:30 AM Central Time
    0884: Risk Score for Early Mortality to stratify for Intensive SSc Therapy
    Location: S102
    Presenting Author: Ann-Christin Pecher, MD – University Hospital Tübingen
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Systemic Sclerosis & Related Disorders – Basic Science Poster I
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Systemic Sclerosis & Related Disorders – Clinical Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0955: Surveying RNA methylation in scleroderma highlights roles for demethylases ALKBH5 and FTO in fibrosis
    Location: Hall F1
    Abstract Poster Presenter: Alexander Cai, BS – University of Michigan
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0956: Mapping Metabolic Changes in Skin Fibrosis in Systemic Sclerosis by Spatial Proteomics
    Location: Hall F1
    Abstract Poster Presenter: Alexandru-Emil Matei, -None- – University Hospital Düsseldorf
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0957: Multi-Omic Profiling Reveals a Monocyte-Vascular Signature Associated with the Regression of Skin Fibrosis in SSc
    Location: Hall F1
    Abstract Poster Presenter: Astrid Hofman, MSc – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0958: Asynchronous Resolution of Inflammation and Fibrosis in a Prolonged Experimental Model Suggests Distinct Temporal Dynamics and Resolution Mechanisms in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Aurore Collet, PhD – University of Lille
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0959: Longitudinal Multiomic Study of Skin, Peripheral Blood, and Serum: Serum Proteome Reflects the Disease Process at the End-organ Level and Predicts the Course of Modified Rodnan Skin Score
    Location: Hall F1
    Abstract Poster Presenter: Bich Na Choi, PhD – UT Health Houston
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0960: Pharmaceutical Blockade of the Neonatal Fc Gamma Receptor Ameliorates Autoimmunity, Inflammation and Fibrosis in the Topoisomerase I Mouse Model of Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Cuong Tran Manh, PhD (he/him/his) – Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University.
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0961: Retinoic acid-related orphan receptor-α: A novel upstream regulator of Hippo signaling and potential therapeutic target in fibrosis
    Location: Hall F1
    Abstract Poster Presenter: Cuong Tran Manh, PhD (he/him/his) – Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University. Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine University.
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0962: Spatial Proteomics Analysis of the organization of tertiary lymphoid structures in Systemic Sclerosis Skin
    Location: Hall F1
    Abstract Poster Presenter: Dennis Bleck, PhD (he/him/his) – University Hospital Düsseldorf, Department of Rheumatology, Hiller Research Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0964: A Single-cell Atlas Reveals Dermal Endothelial Heterogeneity and Disease-specific Pathways in Autoimmune Disorders
    Location: Hall F1
    Abstract Poster Presenter: Jinyi Qian, -None- – Shanghai Jiao Tong University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0965: Inhibition of Nicotinamide N-Methyltransferase Reverses Fibroblast Activation via Epigenetic and Metabolic Remodeling in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Kamal Saba, PhD (he/him/his) – University of Michigan
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0966: Integrated Bulk and Single Cell Analysis Confirms Differential Upregulation of the Proton Sensing Receptor GPR68 in Systemic Sclerosis Across Disease Stage and Subset
    Location: Hall F1
    Abstract Poster Presenter: Kristina Clark, PhD, MBBS, MRCP – University of Oxford
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0967: Single-Cell RNA Sequencing Reveals a Prominent Pro-Inflammatory Gene Signature of Dermal Fibroblasts in Pre-Stages of SSc
    Location: Hall F1
    Abstract Poster Presenter: Lumeng Li, MMSc – University Hospital Zurich, University of Zurich
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0968: Mesenchymal Stromal Cells in Systemic Sclerosis are Dysfunctional and Have a Profibrotic and Senescent Phenotype
    Location: Hall F1
    Abstract Poster Presenter: Marianela Brizio, MD, MSc (she/her/hers) – McGill University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0969: FOXO1 Mediated Polysialic Acid Dysregulation in Severe Systemic Sclerosis (SSc): A Novel Biomarker and Therapeutic Target?
    Location: Hall F1
    Abstract Poster Presenter: Mohammed Osman, MD, PhD, BSc – University of Alberta
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0970: Genomic instability in systemic sclerosis is promoted by metabolic remodelling via a FOXO1-dependent axis
    Location: Hall F1
    Abstract Poster Presenter: Mohammed Osman, MD, PhD, BSc – University of Alberta
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0971: Unraveling the role of the hippo pathway in systemic sclerosis: A focus on TEADs and VGLL3
    Location: Hall F1
    Abstract Poster Presenter: Neha Khanna, -None- – University of Michigan
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0972: Prominent endothelial senescence in systemic sclerosis skin
    Location: Hall F1
    Abstract Poster Presenter: Eliza Pei-Suen Tsou, PhD (she/her/hers) – University of Michigan
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0973: Effects of a Novel Hybrid Protein Based on S100 on Macrophage Polarization and Its Therapeutic Efficacy in a Bleomycin-Induced Systemic Sclerosis Mouse Model.
    Location: Hall F1
    Abstract Poster Presenter: Takuya Kotani, MD, PhD – Osaka Medical and Pharmaceutical University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0974: Tissue resident macrophages derived from induced pluripotent stem cells induce tissue fibrosis in human skin equivalent models of systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Xuezhi Hong, MD – Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0975: Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation
    Location: Hall F1
    Abstract Poster Presenter: Xuezhi Hong, MD – Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0976: LMPTP Drives Fibrosis in Systemic Sclerosis via TGF-beta Signaling Activation
    Location: Hall F1
    Abstract Poster Presenter: Yuan Zhan, n/a (she/her/hers) – Cedars-Sinai Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0977: The nuclear receptor DAX1 regulates WNT/β-catenin signaling to promote fibroblast activation and skin fibrosis in systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Yun Zhang, PhD – University Hospital Erlangen
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1553: Circulating Monocyte Level Is Associated With Pulmonary Vascular Disease and Right Ventricular Dysfunction in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Ai Yaku, MD, PhD – Northwestern University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1554: Demographic, Clinical, and Mortality Trends in Scleroderma Patients with Gastric Antral Vascular Ectasia (GAVE): A National Inpatient Analysis
    Location: Hall F1
    Abstract Poster Presenter: Akanksha Sharma, MD (she/her/hers) – UPMC Mercy Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1555: Prevalence of Organ Involvement and Baseline Predictors of Disease Progression in Patients with Limited Cutaneous Systemic Sclerosis: Insights from the CONQUER Database
    Location: Hall F1
    Abstract Poster Presenter: Alain Lescoat, MD, PhD – CHU Rennes - University Rennes
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1556: Latent Profiles of Parenchymal Abnormalities and Vascular Features Measured by Quantitative CT Identifies a Subgroup of Systemic Sclerosis Patients With a Greater Lung Function Decline Over Time
    Location: Hall F1
    Abstract Poster Presenter: Alicia Hinze, MD, MHS – Mayo Clinic - Rochester, MN
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1557: Association Between Thoracic Muscle and Fat Area and Density and Pulmonary Function in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Aradhna Agarwal, MD, MPH – Columbia University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1558: Gastrointestinal Symptom Severity Is Associated with Worse Patient-reported Outcomes and Dietary Patterns in Systemic Sclerosis: A Single Center Prospective Study
    Location: Hall F1
    Abstract Poster Presenter: Ashima Makol, MD – Mayo Clinic, Rochester, MN
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1559: Anti-cytolethal Distending Toxin Antibodies in Systemic Sclerosis: Associations with Gastrointestinal Disease and Immune Dysregulation
    Location: Hall F1
    Abstract Poster Presenter: Ashish Balar, MBBS, MPH – The University of Texas Health Science Center Houston
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1560: Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease
    Location: Hall F1
    Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1561: Usefulness of HRCT in screening of interstitial lung disease in patients with systemic sclerosis without risk factors of clinical suspicion
    Location: Hall F1
    Abstract Poster Presenter: Carlos De la Puente, MD – Ramón y Cajal University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1562: Vasodilation with Prostanoids Influences Progression of Systemic Sclerosis-Associated Interstitial Lung Disease: a EUSTAR Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1563: RESET-SSc: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), A Fully Human, Autologous 4-1BB CD19-CAR T Cell Therapy in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1564: Validation of a Composite Endpoint for Systemic Sclerosis-Associated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1565: Association of the Gastrointestinal (GI) Microbiome and GI Symptoms in Systemic Sclerosis: An International, Multi-center, Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1566: Factors Associated with Patient and Physician Global Assessments in Early Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Ellen Romich, MD, MSCE – University of Pennsylvania
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1567: Deep-learning analysis of HRCT images predicts progression and mortality in systemic sclerosis-related interstitial lung disease
    Location: Hall F1
    Abstract Poster Presenter: Enrico De Lorenzis, MD,PhD – Catholic University of the Sacred Heart
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1568: A Novel Endothelial Cell Profiling Assay to Identify Systemic Sclerosis Patient Characteristics at the Endothelial Cell Level
    Location: Hall F1
    Abstract Poster Presenter: Eva Hoekstra, MD,MSc (she/her/hers) – Leiden University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1569: Can We Use Patient Reported Outcomes For Home-monitoring in SSc?
    Location: Hall F1
    Abstract Poster Presenter: Eva Hoekstra, MD,MSc (she/her/hers) – Leiden University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1570: Hydroxychloroquine and Disease Progression in Systemic Sclerosis: Insights from Antibody-Stratified Survival Analyses
    Location: Hall F1
    Abstract Poster Presenter: Francesco Bonomi, MD – University Hospital Careggi, Florence
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1571: Spatial Transcriptomics of Perivascular Subepidermal Regions in Very Early Systemic Sclerosis Unveils Cellular and Mitochondrial Stress-Driven Innate Immune Signatures that Initiate Stromal Remodeling
    Location: Hall F1
    Abstract Poster Presenter: Francesco Del Galdo, MD,PhD – University of Leeds
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1572: Compromised intracellular oxygen availability and severe mitochondrial dysfunction in the skeletal muscle of patients with systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Tracy Frech, MD, MS – Vanderbilt University Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1573: WITHDRAWN
    Location: Hall F1
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1574: A Rise in Serum KL-6 Levels Predicts Subsequent Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Keina Yomono, MD – Nippon Medical School
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1575: Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort.
    Location: Hall F1
    Abstract Poster Presenter: Kevin Chevalier – Université Paris Cité
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1576: Impact of COVID-19 Infection on Fibrosis Progression in CTD-Associated ILD: An AI-Based Quantitative CT Study
    Location: Hall F1
    Abstract Poster Presenter: Kyung Ann Lee, MD, PhD (she/her/hers) – Soonchunhyang University Hospital Seoul: Soonchunhyang University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1577: Intravenous cyclophosphamide in the treatment of progressive interstitial lung diseases associated with systemic sclerosis: a prospective randomized trial versus placebo (SCLEROCYC).
    Location: Hall F1
    Abstract Poster Presenter: Luc Mouthon, MD, PhD – Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1578: Use of the CD19/CD3 T cell engager blinatumomab in refractory diffuse systemic sclerosis : a case series
    Location: Hall F1
    Abstract Poster Presenter: Marc Scherlinger, MD,PhD (he/him/his) – Strasbourg University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1579: Exploring the Pulmonary Vascular Changes on Computed Tomography in predicting progression and mortality of Systemic Sclerosis-associated Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1580: Lung Vasculature Quantification on Computed Tomography Predicts New Onset of Interstitial Lung Disease in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1581: The Overall Prevalence and Associated Disease Characteristics of Calcinosis in Systemic Sclerosis: a Systematic Review and Meta-analysis
    Location: Hall F1
    Abstract Poster Presenter: Marie-Elise Martel, MD – Lille University Hospital, France
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1582: Risk factors for incident digital ischemic complications in systemic sclerosis in the Collaborative National Quality and Efficacy Registry (CONQUER)
    Location: Hall F1
    Abstract Poster Presenter: Marissa Savoie, MD – Hospital for Special Surgery
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1583: Epidemiology, Outcome and Expenditures of Hospitalized Patients with Systemic Sclerosis: National Inpatient Sample 2021
    Location: Hall F1
    Abstract Poster Presenter: Patompong Ungprasert, MD, MS – Cleveland Clinic, Cleveland, OH
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1584: Evaluation of Adverse Childhood Experiences in Systemic Sclerosis: Prevalence and Patient Characteristics
    Location: Hall F1
    Abstract Poster Presenter: Samuel Good, MD – University of California, Los Angeles
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1586: Real-World Safety and Efficacy of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched EUSTAR Study
    Location: Hall F1
    Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1587: Longitudinal Clinical Response to JAK Inhibitors in Systemic Sclerosis: A Real-Life Multicentric Study Across Clinical Domains
    Location: Hall F1
    Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1588: Prevalence Of Oral Manifestations And Their Association With Clinical And Serological Profile In Systemic Sclerosis Patients- An Indian Study
    Location: Hall F1
    Abstract Poster Presenter: Tejaswini Ramineni, n/a (she/her/hers) – Esic Medical College And Hospital, Sanathnagar
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1589: Nintedanib in Systemic Sclerosis-Associated Interstitial Lung disease: Real-World Cohort Study on Tolerability and Discontinuation
    Location: Hall F1
    Abstract Poster Presenter: Voon Ong, PhD, FRCP – UCL Medical School Royal Free Campus
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1590: Association of Levels of Soluble CD13 with Clinical Features and Fibrosis in Systemic Sclerosis Patients
    Location: Hall F1
    Abstract Poster Presenter: Yuzo Ikari, MD, PhD – Division of Rheumatology, Department of Medicine, Showa Medical University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1591: Novel autoantibodies in patients with systemic sclerosis and gastrointestinal dysfunction provide insight into disease pathogenesis
    Location: Hall F1
    Abstract Poster Presenter: Zsuzsanna McMahan, MD, MHS – UT Health Houston
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    0963: Increased expression of M2 pro-fibrotic markers in circulating monocytes and cultured monocyte-derived macrophages from systemic sclerosis patients with progressive interstitial lung disease (ILD)
    Location: Hall F1
    Abstract Poster Presenter: Emanuele Gotelli, MD, PhD – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Systemic Sclerosis & Related Disorders – Basic Science Poster II
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Systemic Sclerosis & Related Disorders – Clinical Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2470: Impaired Myocardial Flow Reserve on 82-Rubidium Positron Emission Tomography in Patients with Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Attila Feher, MD, PhD – Yale University School of Medicine - New Haven, CT
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2471: Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use
    Location: Hall F1
    Abstract Poster Presenter: Borja Gracia, MD, PhD – Hospital Clínico Universitario Lozano Blesa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2472: Digesting the data: tracking gastro-intestinal manifestations in systemic sclerosis over time
    Location: Hall F1
    Abstract Poster Presenter: Carina Mihai, MD, PhD – University Hospital Zurich, University of Zurich
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2473: Nailfold Capillaroscopy Improves Cardiovascular Risk Stratification in Systemic Sclerosis: An Adjustment to the SCORE2 Algorithm
    Location: Hall F1
    Abstract Poster Presenter: Carlos Valera Ribera, MD – Hospital Universitario Doctor Peset
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2474: Unveiling the clinical spectrum of ACA-positive SSc-ILD: not as benign as expected
    Location: Hall F1
    Abstract Poster Presenter: Carlos Valera Ribera, MD – Hospital Universitario Doctor Peset
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2475: GERD Severity, Proton Pump Inhibitor Use, and Longitudinal Forced Vital Capacity in the CONQUER Registry
    Location: Hall F1
    Abstract Poster Presenter: Carrie Richardson, MD, MHS – Northwestern University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2476: Blinatumomab in rapid progressive systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Christina Gebhardt, MD – LMU Klinikum
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2477: Current treatment Strategies in Systemic Sclerosis- Interstitial Lung Disease Patients: Real-World Insights from the EUSTAR Cohort (CP138)
    Location: Hall F1
    Abstract Poster Presenter: Corrado Campochiaro, MD – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2478: Endothelial Cell Biomarker Expression Suggests Increased Cell Adhesion in Juvenile SSc, Increased Cytokine Expression in JDM, and an Intermediate Phenotype in Overlap Syndrome Patients
    Location: Hall F1
    Abstract Poster Presenter: Daniel Barnett, PhD, DO – UPMC
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2479: REMS technology 5-y Imminent Fracture Risk in Systemic Sclerosis.
    Location: Hall F1
    Abstract Poster Presenter: Edmund MacLaughlin, MD – Rheumatology Associates of Delmarva
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2480: Respiratory Muscle Weakness in a Systemic Sclerosis Cohort
    Location: Hall F1
    Abstract Poster Presenter: Fabian Mendoza, MD – Thomas Jefferson University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2481: Prevalence and Trends of Suicidal Ideation Among Hospitalized Adults with Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis (2016–2020)
    Location: Hall F1
    Abstract Poster Presenter: Fatima Khdeir, MD – ECU Health Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2482: Characterizing Gastrointestinal Involvement in Systemic Sclerosis: Insights from the National Systemic sclerosis Progression INvestiGation (SPRING) Registry of the Italian Society of Rheumatology
    Location: Hall F1
    Abstract Poster Presenter: Francesco Bonomi, MD – University Hospital Careggi, Florence
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2483: Is There a Seasonal Variation in Raynaud’s Phenomenon Severity in Patients with Systemic Sclerosis?
    Location: Hall F1
    Abstract Poster Presenter: Gulsen Ozen, MD – University of Iowa Carver College of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2484: Phenotype of systemic sclerosis patients with positive anti–NOR-90 antibodies
    Location: Hall F1
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2485: Prevalence of progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease
    Location: Hall F1
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2486: In Vitro Antifibrotic Effects of Nerandomilast on Cell Types Relevant to Intestinal Remodeling and Fibrosis in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Jochen SCHMITZ, n/a – Immunology & Respiratory Disease Research, Boehringer Ingelheim Pharmaceuticals, Inc
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2487: Cardiovascular and venous thromboembolic events in systemic sclerosis: Epidemiological analysis of the Clinical Practice Research Datalink
    Location: Hall F1
    Abstract Poster Presenter: John Pauling, PhD, BSc, FRCP, MBBCH – North Bristol NHS Trust & University of Bristol Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2488: Efficacy and Safety of Rituximab for Skin Involvement in Systemic Sclerosis: A Single-Center Study
    Location: Hall F1
    Abstract Poster Presenter: Kanako Chujo, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2489: Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
    Location: Hall F1
    Abstract Poster Presenter: Kevin Chevalier – Université Paris Cité
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2490: Unmasking Mortality Risk: The Impact of Systemic Sclerosis in Stress-Induced Cardiomyopathy
    Location: Hall F1
    Abstract Poster Presenter: Laura Rojo Grajales, MD – Nassau University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2491: High Prevalence of Autoimmunity and Cancer in Anti-NOR90-positive Patients: A Multicenter Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Marina Dueñas Ochoa, MD (she/her/hers) – Hospital La Princesa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2492: Autoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
    Location: Hall F1
    Abstract Poster Presenter: Marzieh Jamali, MD (she/her/hers) – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2493: Investigating scoring systems to measure clinically relevant changes in systemic sclerosis-related finger acro-osteolysis over time, as assessed in serial hand radiographs
    Location: Hall F1
    Abstract Poster Presenter: Michael Hughes, PhD,MBBS,BSc,MSc,MRCP (he/him/his) – The University of Manchester
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2494: Abatacept Reduces CD319+ (SLAM-F7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Mikel Gurrea-Rubio, PhD – University of Michigan - Ann Arbor
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2495: IL-6/STAT3 Signaling is Central for Chemokine Production in E2-Induced Dermal Inflammation
    Location: Hall F1
    Abstract Poster Presenter: Nicolas Ancona, B.S. – MUSC Rheumatology & Immunology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2496: Comparing Long-term Outcome Across Systemic Sclerosis Subgroups Using a Multi-Organ Disease Progression Score
    Location: Hall F1
    Abstract Poster Presenter: Philip Yee, MD – UCL
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2497: Unraveling the Complexity of Interferon Responses in Peripheral Blood Mononuclear Cells in Systemic Sclerosis at Single-Cell Resolution
    Location: Hall F1
    Abstract Poster Presenter: Pietro Bearzi, MD – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2498: Effect of autologous myeloablative hematopoietic stem cell transplantation on skin and peripheral blood mononuclear cells in systemic sclerosis patients with interstitial lung disease
    Location: Hall F1
    Abstract Poster Presenter: Poulami Dey, PhD – Michigan Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2499: Concomitant Anti-Ro/SSA Antibodies in Systemic Sclerosis Patients is Associated with Risks Beyond Dryness
    Location: Hall F1
    Abstract Poster Presenter: Rachael Gordon, MD, PhD – University of Pittsburgh
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2500: Greater Economic Burden and Healthcare Resource Utilization in Patients with Systemic Sclerosis With Versus Without Interstitial Lung Disease: Results from a Systematic Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Roger Abramino Levy, MD, PhD – GSK, Rheumatology, Global Medical Affairs
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2501: Microvascular dysfunction contributes to hand bone deterioration in SSc patients
    Location: Hall F1
    Abstract Poster Presenter: Rosanna Campitiello, MD – University of Genoa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2502: Deciphering Systemic Sclerosis Phenotypes: A Novel Approach Using Clustering Algorithms and Proteomic Insights. Results from the PRECISESADS Study
    Location: Hall F1
    Abstract Poster Presenter: Santiago Dans Caballero, MD – H. U. Reina Sofía
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2503: Validation of a Composite Biomarker Score To Predict Modified Rodnan Skin Score: Insight From Autologous Stem Cell Transplantation International Scleroderma trial
    Location: Hall F1
    Abstract Poster Presenter: Stefano Rodolfi, MD – University College London
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1860: GLUT and FAPα as molecular imaging markers for interstitial lung disease in systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1857: Role of autoantigen-specific reactivity in the pathogenesis of murine interstitial lung disease model with anti-MDA5 antibody mouse model
    Location: Hall F1
    Abstract Poster Presenter: Atsubumi Ogawa, MD – Kyoto University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1856: Spatial Proteomic-based Phenotyping of Fibroblast Populations and their Microenvironment in Systemic Sclerosis Primary Heart Involvement
    Location: Hall F1
    Abstract Poster Presenter: Andrea-Hermina Györfi, MD – Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1867: Deciphering the Molecular Landscape of the Small Intestine in Early and Late SSc Using High-Definition Spatial Transcriptomics
    Location: Hall F1
    Abstract Poster Presenter: Laura Much, MSc – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1861: Accelerated and Gene-specific Patterns of Clonal Hematopoiesis Distinguish Subtypes of Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Brecca Miller, n/a (she/her/hers) – Center for Human Genetics and Genomics, NYU Grossman School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1870: Paracrine WNT Signaling Modulates Profibrotic Macrophage Metabolic Activation in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Patricia Pioli, PhD – Geisel School of Medicine at Dartmouth
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1875: Fcγ-receptor activation by circulating immune complexes in autoimmunity and CD19.CAR-T cell therapy
    Location: Hall F1
    Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1863: bag3 in Systemic Sclerosis: Possible Therapeutic Target and Biomarker for Pulmonary Fibrosis
    Location: Hall F1
    Abstract Poster Presenter: Claudia Iannone, MD – University of Milan, Gaetano Pini CTO
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1872: High-throughput Screening Uncovers Distinct Molecular Signatures Linked with HRCT Patterns in SARD-ILD
    Location: Hall F1
    Abstract Poster Presenter: Philip Stauffer, PhD – University of Zurich Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1864: Mitochondrial Dysfunction Drives cGAS-STING–Mediated Type I Interferon Production and Fibrosis in Systemic Sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Giulio Forte, n/a – Università della Campania Luigi Vanvitelli
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1866: Elucidating gastric pathology in systemic sclerosis using single-cell RNA sequencing
    Location: Hall F1
    Abstract Poster Presenter: Kristina Clark, PhD, MBBS, MRCP – University of Oxford
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1874: Neutrophil Extracellular Trap-Rich Systemic Sclerosis Plasma Promotes Microvascular Endothelial Cell Proliferation and Migration: Implications for Aberrant Angiogenesis
    Location: Hall F1
    Abstract Poster Presenter: Wenying Liang, PhD, MBBS – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1868: Global Downregulation of Fli1 in Mice Induces Cardiac Dysfunction via Enhanced β-fatty acid Oxidation and Collagen Deposition
    Location: Hall F1
    Abstract Poster Presenter: Moyo Mudhibadhi, PhD (he/him/his) – Boston University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1859: Unraveling Disparities in Systemic Lupus Erythematosus-Related Mortality Among U.S. Adults (≥25 Years) with Malignancy: A Longitudinal Analysis of Gender, Race, and Geographic Inequities Using CDC WONDER (1999–2020)"
    Location: Hall F1
    Abstract Poster Presenter: Ayesha Khan, n/a – Dow Medical College
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1873: TGF-β-Driven Mitochondrial Stress Activates cGAS-STING Signalling via Impaired Mitophagy in Systemic Sclerosis Endothelial Cells
    Location: Hall F1
    Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1871: Examining the Impact of ETV2 on altered endothelial phenotype in systemic sclerosis
    Location: Hall F1
    Abstract Poster Presenter: Eliza Pei-Suen Tsou, PhD (she/her/hers) – University of Michigan
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1876: Targeting the NK cell checkpoint NKG2A promotes lung fibrosis resolution by enhancing immune clearance of senescent myofibroblasts
    Location: Hall F1
    Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1865: Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multi-omics analysis
    Location: Hall F1
    Abstract Poster Presenter: Hanlin Yin, MD, PhD – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1858: Antinuclear Antibodies from Systemic Sclerosis Patients Enter Cells via a Clathrin Endocytosis Mechanism and Interact with Their Intracellular Antigen
    Location: Hall F1
    Abstract Poster Presenter: Aurélien Chepy, -None- (he/him/his) – INFINTE U186 inserm, univeristy of Lille
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1862: Comprehensive analysis of the major histocompatibility complex in systemic sclerosis-associated interstitial lung disease identifies novel associated loci and potential progression biomarkers
    Location: Hall F1
    Abstract Poster Presenter: Carlos de la Rosa Báez, MSc – Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, CSIC
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1855: Small Bowel Microbial Dysbiosis and Impaired Intestinal Absorptive Function in Systemic Sclerosis- A Single Center Prospective Study
    Location: Hall F1
    Abstract Poster Presenter: Adam Edwinson, PhD – Mayo Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    1869: A Mirna Signature Consisting of High let7i-5p, High mir-483-5p, Low mir-223- 3p Characterizes Connective Tissue Diseases with Interstitial Lung Disease
    Location: Hall F1
    Abstract Poster Presenter: Olga Sanchez Pernaute, MD,PhD (she/her/hers) – Clinica Universidad de Navarra
  • Wednesday, Oct 29th
    9:30 AM - 11:00 AM Central Time
    29W05: Abstracts: Systemic Sclerosis & Related Disorders – Clinical III
    Location: W196A-C
    Abstract Moderator: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
    Abstract Moderator: Mohammed Osman, MD, PhD, BSc – University of Alberta
     CE: 0.00
  • Wednesday, Oct 29th
    9:30 AM - 9:45 AM Central Time
    2651: Development and Validation of the Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement
    Location: W196A-C
    Presenting Author: Laura Ross, MBBS PhD FRACP – The University of Melbourne
  • Wednesday, Oct 29th
    9:45 AM - 10:00 AM Central Time
    2652: Anti-mitochondrial Antibodies in Systemic Sclerosis Target Enteric Neurons and Are Associated with GI Dysmotility
    Location: W196A-C
    Presenting Author: Subhash Kulkarni, PhD – BIDMC
  • Wednesday, Oct 29th
    10:00 AM - 10:15 AM Central Time
    2653: First Prospective Evaluation of Recombinant Herpes Zoster Vaccine in Systemic Sclerosis: Immunogenicity, Safety, and Disease Activity Outcomes
    Location: W196A-C
    Presenting Author: ANA PAULA LUPPINO-ASSAD, MD, PhD – Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)
  • Wednesday, Oct 29th
    10:15 AM - 10:30 AM Central Time
    2654: Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
    Location: W196A-C
    Presenting Author: Ellen Romich, MD, MSCE – University of Pennsylvania
  • Wednesday, Oct 29th
    10:30 AM - 10:45 AM Central Time
    2655: Fetal and maternal outcomes in systemic sclerosis and very early diagnosis of systemic sclerosis pregnancies, a national prospective study
    Location: W196A-C
    Presenting Author: Anne Murarasu, MD – Ecole doctorale Pierre Louis de Santé Publique
  • Wednesday, Oct 29th
    10:45 AM - 11:00 AM Central Time
    2656: Long-term effect of selexipag in systemic sclerosis-associated digital ulcers: a case control, multicentre, observational study
    Location: W196A-C
    Presenting Author: Claudia Iannone, MD – University of Milan, Gaetano Pini CTO